<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><description>药通社：政策、资讯、产业、技术</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 14 Jun 2021 23:19:51 +0800</pubDate><image><url>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</url><title>药通社 | wechat-feeds</title><link>http://MzU5NjUwOTgyNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>​仿制药BE结果是否确为临床等效的金标准？</title><link>https://mp.weixin.qq.com/s/yhn_qFMtIybQtFacgIA0YA</link><description></description><content:encoded><![CDATA[​仿制药BE结果是否确为临床等效的金标准？]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>江苏威凯尔1类新药，JAK1抑制剂VC005临床申请获受理</title><link>https://mp.weixin.qq.com/s/WAhttjF4V9n-xArNPqmL_w</link><description></description><content:encoded><![CDATA[江苏威凯尔1类新药，JAK1抑制剂VC005临床申请获受理]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>嘉宾发布！2021中国（苏州）抗体药物、细胞和基因治疗峰会邀您共赴行业盛会！</title><link>https://mp.weixin.qq.com/s/W_43Tuai1_UuCBBpqfPr0w</link><description></description><content:encoded><![CDATA[嘉宾发布！2021中国（苏州）抗体药物、细胞和基因治疗峰会邀您共赴行业盛会！]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/ir8fReiOB3m_Cnk_RgOzBQ</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>制药人才网！了解下哦！</title><link>https://mp.weixin.qq.com/s/bsPipiIfpgOCU6fQjcirYg</link><description></description><content:encoded><![CDATA[制药人才网！了解下哦！]]></content:encoded><pubDate>Mon, 14 Jun 2021 19:30:07 +0800</pubDate></item><item><title>恒瑞：连续3年入选全球制药企业50强！2021还有4家中国药企入选！</title><link>https://mp.weixin.qq.com/s/rIbif_9e5ZBXQVtKvWwLAg</link><description></description><content:encoded><![CDATA[恒瑞：连续3年入选全球制药企业50强！2021还有4家中国药企入选！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>大手笔！泰格医药：98亿参与设立生命健康产业基金！</title><link>https://mp.weixin.qq.com/s/njnnP2AaT0a3xDyF90ycvg</link><description></description><content:encoded><![CDATA[大手笔！泰格医药：98亿参与设立生命健康产业基金！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/RTFeU3whtRmwHg_LkPY9vQ</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>制药人才网！了解下哦！</title><link>https://mp.weixin.qq.com/s/PFcK-pgMGDPf1ZHB_m_R1g</link><description></description><content:encoded><![CDATA[制药人才网！了解下哦！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>合集 | 靶点社往期精彩文章！</title><link>https://mp.weixin.qq.com/s/U2JBwyX3LqOBNtnOr3svnQ</link><description></description><content:encoded><![CDATA[合集 | 靶点社往期精彩文章！]]></content:encoded><pubDate>Sun, 13 Jun 2021 22:28:02 +0800</pubDate></item><item><title>5月份，FDA 批准上市新药汇总</title><link>https://mp.weixin.qq.com/s/afzJ1ZK5GstkpOSUM3waww</link><description></description><content:encoded><![CDATA[5月份，FDA 批准上市新药汇总]]></content:encoded><pubDate>Sat, 12 Jun 2021 22:04:32 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/OtkHy09MvZ23GIS1T_Rg5g</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Sat, 12 Jun 2021 22:04:32 +0800</pubDate></item><item><title>(6.01-6.10):四批药品批件！过评73个，含9款首家…鲁南制药新添抗肿瘤品种，已过评17个品种(附清单)</title><link>https://mp.weixin.qq.com/s/JDAP8MIysH2WWiZk4yaS8g</link><description></description><content:encoded><![CDATA[(6.01-6.10):四批药品批件！过评73个，含9款首家…鲁南制药新添抗肿瘤品种，已过评17个品种(附清单)]]></content:encoded><pubDate>Sat, 12 Jun 2021 22:04:32 +0800</pubDate></item><item><title>原料药粒度研究在创新药开发中的应用</title><link>https://mp.weixin.qq.com/s/mwwBDAw-wyzOTOlUvsh9aA</link><description></description><content:encoded><![CDATA[原料药粒度研究在创新药开发中的应用]]></content:encoded><pubDate>Sat, 12 Jun 2021 22:04:32 +0800</pubDate></item><item><title>制药人才网！了解下哦！</title><link>https://mp.weixin.qq.com/s/yO_uQynTq3qV_hfyCCj3mw</link><description></description><content:encoded><![CDATA[制药人才网！了解下哦！]]></content:encoded><pubDate>Sat, 12 Jun 2021 22:04:32 +0800</pubDate></item><item><title>已导致3名专家辞任！FDA争议AD新药​Aduhelm！</title><link>https://mp.weixin.qq.com/s/GPtp3uYzcP18KmymA6Mz1Q</link><description></description><content:encoded><![CDATA[已导致3名专家辞任！FDA争议AD新药​Aduhelm！]]></content:encoded><pubDate>Fri, 11 Jun 2021 09:59:57 +0800</pubDate></item><item><title>505(b)(2)/新药的立项策略，让您成为20%成功者的一员</title><link>https://mp.weixin.qq.com/s/voLTzxClnrMy3ReDLPc40w</link><description></description><content:encoded><![CDATA[505(b)(2)/新药的立项策略，让您成为20%成功者的一员]]></content:encoded><pubDate>Fri, 11 Jun 2021 09:59:57 +0800</pubDate></item><item><title>邀请函丨重庆恒誉康医药诚邀您莅临改良型新药趋势及技术峰会</title><link>https://mp.weixin.qq.com/s/gqPwI_LBACm9CpJEAqpJUQ</link><description></description><content:encoded><![CDATA[邀请函丨重庆恒誉康医药诚邀您莅临改良型新药趋势及技术峰会]]></content:encoded><pubDate>Fri, 11 Jun 2021 09:59:57 +0800</pubDate></item><item><title>企业 | 深耕CD47靶点新药，宜明昂科多新药/适应症国内申报临床</title><link>https://mp.weixin.qq.com/s/oFQ93QA3YeJWhikXZ_VMuQ</link><description></description><content:encoded><![CDATA[企业 | 深耕CD47靶点新药，宜明昂科多新药/适应症国内申报临床]]></content:encoded><pubDate>Fri, 11 Jun 2021 09:59:57 +0800</pubDate></item><item><title>Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧</title><link>https://mp.weixin.qq.com/s/uC7yq3hfBvo6CclFHadk_Q</link><description></description><content:encoded><![CDATA[Hi，医药人！这个八月跟着药融圈全面玩转CMC-China吧]]></content:encoded><pubDate>Fri, 11 Jun 2021 09:59:57 +0800</pubDate></item></channel></rss>